Millennium Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.91M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $12.1M | Buy |
|
|||||
|
2023
Q4 | $2.33M | Buy |
|
|||||
|
2023
Q3 | $463K | Sell |
|
|||||
|
2023
Q2 | $1.11M | Sell |
|
|||||
|
2023
Q1 | $1.08M | Buy |
|
|||||
|
2022
Q4 | $1.41M | Buy |
|
|||||
|
2022
Q3 | $429K | Buy |
|
|||||
|
2022
Q2 | $264K | Buy |
|
|||||
|
2022
Q1 | $975K | Buy |
|
|||||
|
2021
Q4 | $905K | Sell |
|
|||||
|
2021
Q3 | $4.25M | Sell |
|
|||||
|
2021
Q2 | $3.78M | Buy |
|
|||||
|
2021
Q1 | $2.94M | Sell |
|
|||||
|
2020
Q4 | $3.61M | Buy |
|
|||||
|
2020
Q3 | $386 | Sell |
|
|||||
|
2020
Q2 | $1.7M | Buy |
|
|||||
|
2020
Q1 | $65K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $520K | Buy |
|
|||||
|
2019
Q1 | $117K | Sell |
|
|||||
|
2018
Q4 | $156K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $5.04M | Buy |
|
|||||
|
2018
Q1 | $736K | Buy |
|
|||||
|
2017
Q4 | $75K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $230K | Sell |
|
|||||
|
2016
Q2 | $304K | Buy |
|